Health Care: Drugs

Horizon Pharma PLC (HZNP: NASDAQ)

$29.61 -0.54 | -1.79%
09/03/15 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 30.15
52 Week High 39.49
52 Week Low 9.60
Avg. Daily Vol. (Mil) 3.16
Beta (3 year) 1.32
Share Related Items
Mkt Cap (Mil) 4,799.91
Shares Out (Mil) 159.20
Float (Mil) 121.35
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.90
Current Ratio 3.10
LT Debt/ Equity 0.90
Total Debt / Equity 0.91
Valuation Ratios
Price Earnings 324.90
Price/Sales 10.32
Price/Book 3.83
Price/Cash Flow 58.50
Per Share Data
Earnings 0.09
Sales 2.92
Book Value 7.88
Cash Flow 0.52
Business Summary
Horizon Pharma PLC is a specialty pharmaceutical company. The Company's product portfolio consists of ACTIMMUNE, DUEXIS, PENNSAID 2% and RAYOS/LODOTRA, which addresses the unmet therapeutic needs in arthritis, pain, inflammatory and/or orphan diseases.
General Information
1 Burlington Road
Connaught House, 1st Floor
Dublin 4, 60015
www.horizonpharma.com
Industry : Drugs
Sector: Health Care
Employees: 692
CEO: Mr. Timothy P. Walbert
Short Interest
Current Month (Mil) 8.21
Previous Month (Mil) 8.97
Short Interest Ratio (Days) 2.70
Management Effectiveness
Return on Equity n.a.
Return on Assets -0.60
Return on Investments -0.70
Profitability
Gross Margin 91.90
EBIT Margin -29.50
Profit Margin -3.70

Portfolios with HZNP

Latest HZNP Headlines from TheStreet

More Financial News for HZNP

Press Releases for HZNP

See All Press Releases

Partner Headlines for HZNP

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter